Precautions and Warnings With Sibutramine

Precautions and warnings with sibutramine should be reviewed with your healthcare provider prior to beginning treatment. This includes telling him or her if you have a history of heart problems, liver or kidney disease, or glaucoma. You should also be aware of potential side effects of sibutramine and how they may be avoided. Precautions and warnings with sibutramine also extend to people with certain allergies and women who are pregnant or breastfeeding.

Sibutramine: What Should I Tell My Healthcare Provider?

In October 2010, sibutramine hydrochloride was withdrawn from the market in the United States. Studies have shown that it increases the risk of heart attacks and strokes. This medication will no longer be available in the United States. People should stop taking it and should ask their healthcare providers about more appropriate weight loss options. 
You should talk with your healthcare provider prior to taking sibutramine hydrochloride monohydrate (Meridia®) if you have:
Also, let your healthcare provider know if you are:
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
You should also be sure to tell your healthcare provider about any other medicines you are taking, including prescription and non-prescription medicines, vitamins, and herbal supplements.
Last reviewed by: Kristi Monson, PharmD
10 Simple Ways to Lose Weight